NEWTON, Mass.--(BUSINESS WIRE)--Clinical Data, Inc. (NASDAQ: CLDA) announced today that its Cogenics division, the global leader in outsourced genomics services, has become the exclusive global provider of genotyping solutions for Astellas Pharma Inc. Cogenics’ offerings will include biorepository and extraction services in combination with whole genome association and targeted genotyping for Astellas’ clinical studies in the United States, Europe and Asia.
